Interview Guide for Laypersons

Form Approved

OMB No.: 0920-xxxx

Expiration Date: XX/XX/XXXX

Public Reporting burden of this collection of information is estimated at 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NW, MS D-74, Atlanta, GA  30333; Attn:  PRA (0920-XXXX).

Interview Guide PDO/naloxone laypersons

Hello, this is _______________ with Battelle. Thank you for agreeing to participate in today’s interview. Battelle is a research organization and we are working with the Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Agency (SAMHSA) to conduct an evaluation of naloxone education and distribution in your community. The evaluation is intended to help understand the scope and impact of naloxone on overdose deaths, increase our understanding of program effectiveness, and increase understanding of barriers and facilitators to distributing naloxone. You have been asked to participate because we are interested in learning about your perspective and experiences with naloxone.

If you agree to participate in the interview, we will ask you a series of questions related to naloxone. This interview will take about 60 minutes or less of your time. Your participation is completely voluntary. You can decide whether or not to participate. If you do agree to participate, you may stop at any time. You may also choose to not answer any questions. Should you choose to participate, your answers will be maintained in a secure manner and you will not be identified by name or description in any reports.

Do you have any questions for me?

Are you willing to participate in the interview?

We would also like to audio tape the interview for transcribing purposes only. You will not be identified by name or description in any of the audio recordings. Once the interviews have been transcribed, the tapes will be erased.

Are you willing to have the interview audio taped?

[Begin recording]

1. How did you first learn about naloxone?

2. What is your personal experience with naloxone?

Probe: Administered naloxone? Use naloxone? Trained on how to use naloxone?

If use or administered naloxone:

3. How did you obtain naloxone?

Probe: Was it difficult to get? How could obtaining it be made easier?

Probe: Was it free or did you pay for it?

4. Were you trained to use/administer naloxone? If so, by whom?

5. [If trained] Thinking about when you were trained, what aspects of the training were most effective? Least effective?
   Probe: What did you like best/least about the training.

6. [If trained] What aspects of the training could be made better in the future?

7. [If administer naloxone] Please describe your experiences with administering naloxone

Probe: Is it easy to administer?

Probe: What challenges have you experienced with administering naloxone? How did you address these challenges?

Probe: what have been the results of your administering naloxone?

8. What are your thoughts about naloxone? (Probe: Both positive and negative thoughts are welcome)

9. Do you think your community is supportive or unsupportive of naloxone? Why?

10. Is there anything else you’d like to tell us?

Conclusion

Thank you so much for your time today. Your input will help us better understand how the PDO/naloxone grant funding is being used in your community. What we learn from this will help other communities in the future as well. So, again, thank you.